Malaria, Mosquitoes & Sickle Cell

Scroll to see how Anopheles mosquito distribution, malaria incidence, and sickle cell disease overlap geographically — revealing the evolutionary pressure that made a deadly blood disorder a survival advantage.

Scroll to continue

Anopheles Mosquito Distribution

Of the roughly 500 known Anopheles species, about 40 are competent malaria vectors. The genus thrives in tropical and subtropical climates where standing water, warm temperatures, and humidity support larval development. Countries are shaded by GBIF occurrence records — a proxy for species diversity and surveillance effort. Sub-Saharan Africa dominates, home to Anopheles gambiae and Anopheles funestus, the most efficient vectors of Plasmodium falciparum. Southeast Asia harbors a distinct complex including Anopheles dirus and Anopheles minimus, adapted to forest-fringe habitats. Note that the United States appears heavily shaded despite having eliminated malaria in 1951 — this reflects sampling bias, not vector competence. U.S. institutions contribute disproportionately to GBIF, and decades of well-funded entomological surveillance have generated far more digitized specimen records per capita than most tropical countries where Anopheles actually transmits disease. Gaps elsewhere often reflect limited sampling rather than true absence.

GBIF.org (24 March 2026) GBIF Occurrence Download https://doi.org/10.15468/dl.zffc2v

Malaria Incidence

WHO estimated number of malaria cases by country (2021). Nigeria alone accounts for roughly 65 million cases — about 27% of the global total. Five species of Plasmodium infect humans, but P. falciparum causes over 90% of deaths, concentrated in sub-Saharan Africa. The parasite's complex life cycle — sexual reproduction in the mosquito, asexual multiplication in human liver and red blood cells — makes eradication exceptionally difficult. Notice how the case burden tracks the vector distribution: where Anopheles density is highest, malaria follows. Countries with zero cases in the tropics (e.g., Sri Lanka) represent hard-won elimination successes through vector control, surveillance, and treatment access. This map uses absolute case counts rather than per-capita rates to parallel the sickle cell data below — both show total burden, making the geographic overlap between the two diseases directly comparable. The tradeoff is that populous countries like Nigeria and the DRC dominate the color scale; a per-capita view would more evenly highlight smaller high-burden nations like Niger and Burkina Faso.

World Health Organization. Global Health Observatory — Estimated number of malaria cases, 2021. https://www.who.int/data/gho

Sickle Cell Disease

Sickle cell disease arises from a point mutation in the β-globin gene (HBB, Glu6Val) that causes hemoglobin S to polymerize under low oxygen, deforming red blood cells into rigid sickle shapes. Homozygous individuals (HbSS) suffer chronic hemolytic anemia, vaso-occlusive crises, and organ damage. Yet heterozygous carriers (HbAS) gain significant protection against severe P. falciparum malaria — sickled cells are cleared faster by the spleen, and the parasite grows poorly in HbS erythrocytes. This heterozygote advantage has maintained allele frequencies as high as 15–20% in malaria-endemic West and Central Africa over thousands of generations, a textbook case of balancing selection. Compare this map to the malaria layer above: the geographic overlap is striking evidence that infectious disease has shaped human genetics.

Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Global Burden of Disease Study 2021 (GBD 2021) Sickle Cell Disease Estimates 2000-2021. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2023.